Target intelligence / Profile preview

S100 calcium-binding protein P (S100P)

Target
S100P
Molecular classification
Calcium-binding protein, EF-hand protein (helix-loop-helix motif)
01

Overview

S100 calcium-binding protein P is a small (11 kDa) member of the S100 protein family characterized by two EF-hand motifs that bind calcium ions, as well as zinc and magnesium. S100P is expressed in various tissues including placenta, stomach, bladder, and bone marrow and is upregulated in several cancers. It regulates key processes such as cell proliferation, differentiation, survival, migration, and invasion by interacting with proteins like ezrin and RAGE. S100P acts both within cells and as an extracellular signaling molecule, modulating cytoskeletal dynamics, extracellular matrix remodeling, and gene transcription. In oncology, overexpression of S100P correlates with tumor aggressiveness, metastasis, and resistance to chemotherapy, making it a candidate prognostic biomarker and potential therapeutic target, especially in breast and prostate cancer.

Other names
S100PProtein S100-PS100EMIG9Migration-inducing gene 9 proteinProtein S100-ES100 calcium-binding protein P
02

Mechanism of action

Drugs such as cromolyn and pentamidine inhibit the interaction between S100P and the receptor for advanced glycation end products (RAGE), which mediates cell signaling important for tumor growth and migration.

03

Biological functions

Calcium homeostasisCell proliferationCell cycle regulationApoptosisCell migration and invasionRegulation of cytoskeleton and extracellular matrix interactionsRegulation of transcription factors
04

Disease associations

Cancer (especially breast cancer, prostate cancer, and other solid tumors)InflammationMetastasisChemoresistance
05

Safety considerations

No significant direct safety concerns reported; therapeutic targeting may risk altering calcium signaling or cell cycle regulation, with implications for both normal and tumor cells.
06

Interacting drugs

Cromolyn

1 more in the full profile.

07

Biomarkers

S100P expression level (prognostic and predictive biomarker in breast and prostate cancer)S100P reduction after chemotherapy (correlates with response, especially in HER2+ breast cancer)

Beyond the preview

Go deeper on S100 calcium-binding protein P (S100P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on S100 calcium-binding protein P (S100P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call